Mevion Medical looks to go public with a $69 million stock offering as it gears up to scale its proton therapy device.
Mevion Medical registered for a $69 million initial public offering as it gears up to commercialize its proton therapy system.
Group purchasing organizations Premier selects radiosurgery devices maker Accuray for an exclusive 3-year contract.
Accuray (NSDQ:ARAY) touted landed a new exclusive contract to offer its CyberKnife M6 and TomoTherapy HDA devices to members of Premier Inc. at special rates.
Accuray says it's agreed to settle the patent infringement and poaching lawsuits it had going against Best Medical.
Varian passes on an acquisition option as Augmenix closes a Series D funding round with $10.8 million raised in support of its Space OAR hydrogel for protecting the rectum during prostate radiation therapy.
Massachusetts-based Augmenix is hoping it can make it to the U.S. market with the $10.8 million funding round it just closed, the company said this month.
Elekta hopes to meet Turkey's radiotherapy "shortage" through its acquisition of local distributor Mesi Medikal.
California medtech maker Accuray boosts its full-year revenue outlook after posting Q3 2014 sales nearly 40% higher than last year.
Radiosurgery systems maker Accuray (NSDQ:ARAY) sees continued momentum on the horizon as a boost in Q3 sales prompts an updated, increased full-year outlook.
California-based Varian Medical System shaves 16¢ off of its per-share earnings for charges related to a patent infringement settlement with the University of Pittsburgh.
Radiosurgery devices maker Varian Medical (NYSE:VAR) posted a tough quarter, with sales up a modest 1.3% and earnings sucked up by legal charges in its 2nd quarter.